In this Brownstone Institute article, concerns are raised about the World Health Organization’s efforts to establish a global vaccine authorization system that could override national regulatory authority.
- The WHO is reportedly developing a framework that would allow vaccines to be approved at a supranational level rather than through individual countries.
- This system could rely on “emergency use listings” that bypass traditional, country-specific regulatory scrutiny.
- Critics argue the mechanism may centralize power in unelected global institutions, reducing national sovereignty over health decisions.
- The article highlights how regulatory standards could be harmonized globally, potentially lowering the bar for approval in some regions.
- Concerns are raised that liability protections for vaccine manufacturers may be expanded under such a system.
- The initiative is linked to broader pandemic preparedness agreements and amendments being discussed internationally.
- Skeptics warn that this could create a permanent infrastructure for rapid vaccine rollout without sufficient long-term safety evaluation.
- Supporters claim the system would improve global response speed and equity during future health crises.
Read the full story: https://brownstone.org/articles/the-who-is-building-a-supranational-vaccine-authorization-mechanism/
